Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moderna COVID-19 Booster in Hematologic Malignancies
NCT05028374Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Aug 2021
- Primary completion
- Nov 2021
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of elasomeran in coronavirus disease 2019 (COVID-19), sponsored by Barbara Ann Karmanos Cancer Institute. Started Aug 2021; status: completed.
02
Drugs
elasomeran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05028374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05028374.